AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 35792253
Drug: Antimicrobial photodynamic
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimicrobial photodynamic therapy (aPDT) on the tongue surface
Trial: 33558662
Drug: Cryotherapy +
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cryotherapy + GM-CSF (Treatment group)
Trial: 33384335
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment - exclusive enteral nutrition (EEN) or oral prednisolone (1 mg/kg, max 40 mg)
Trial: 34787952
Drug: 25 g
RxNorm normalized name: AndroGel 1.25 g Packets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 g of d‐β‐hydroxybutyrate (βHB) in the form of a KE drink (ΔG®) with 2 g of L‐alanine
Trial: 34054112
Drug: lumateperone 42
RxNorm normalized name: lumateperone 42 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lumateperone 42 mg
Trial: 38546622
Drug: Cognitive Processing
RxNorm normalized name: Allogeneic processed thymus tissue
DrugBank: Allogeneic processed thymus tissue (DB16736)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Processing Therapy (CPT)
Trial: 34615779
Drug: Intralesional infiltration
RxNorm normalized name: CD8+ enriched young tumor infiltrating lymphocytes
DrugBank: CD8+ enriched young tumor infiltrating lymphocytes (DB17460)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional infiltration of 2 mL dexamethasone (4 mg/mL) + hyaluronidase 1500 IU dissolved in 0.5 mL of 2% lignocaine twice a week for 3 months
Trial: 35553047
Drug: Pregabalin 300
RxNorm normalized name: pregabalin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin 300 mg
Trial: 32895281
Drug: Liberal transfusion
RxNorm normalized name: dextromethorphan
DrugBank: Dextromethorphan (DB00514)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liberal transfusion strategy (target Hb levels of 100-120 g/L)
Trial: 36107424
Drug: Weekly participation
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly participation rates
Trial: 35011752
Drug: Pharmacopuncture therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacopuncture therapy
Trial: 39499309
Drug: Ibuprofen 400
RxNorm normalized name: ibuprofen 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 400 mg
Trial: 33347632
Drug: Anti-CGRP monoclonal
RxNorm normalized name: Anti-VEGF monoclonal antibody
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Anti-CGRP monoclonal antibodies
Trial: 33068343
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group with basic treatment of internal medicine and rehabilitation training
Trial: 36378691
Drug: Dual-therapy CD34
RxNorm normalized name: miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent (DTS)
Trial: 34127624
Drug: Routine physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine physical therapy alone for 3 weeks
Trial: 33917916
Drug: 6 week
RxNorm normalized name: tobramycin 28 MG inhalation powder 56 Weekly Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 week low-dose combined resistance and endurance training program (TG)
Trial: 34373362
Drug: Sodium alginate
RxNorm normalized name: Sodium Alginate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium alginate (orally administered for 3 days after EGD)
Trial: 32907500
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg donafenib twice daily for 24 weeks
Trial: 36153518
Drug: Fruit and
RxNorm normalized name: elderberry fruit and flower 460 mg-115 mg ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fruit and Vegetable Intervention Arm (weekly counseling and supplemental fruit and vegetable box delivery for 20 weeks)
Trial: 32897570
Drug: Aprocitentan 10
RxNorm normalized name: Aprocitentan
DrugBank: Aprocitentan (DB15059)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aprocitentan 10 mg/day for 9 days
Trial: 35684031
Drug: Syrup
RxNorm normalized name: Syrup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Syrup
Trial: 33814231
Drug: Peak anti-HBs
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peak anti-HBs levels in 100–1000 mIU/mL or ≥ 1000 mIU/mL
Trial: 32109194
Drug: Cladribine monotherapy
RxNorm normalized name: Cladribine
DrugBank: Cladribine (DB00242)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cladribine monotherapy
Trial: 38846755
Drug: Secukinumab 150
RxNorm normalized name: secukinumab 150 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Secukinumab 150 mg
Trial: 32584425
Drug: Antiparasitic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiparasitic treatment with albendazole
Trial: 33493023
Drug: 40 g
RxNorm normalized name: PEG-40 GLYCERYL STEARATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 g of soybean protein (soy40)
Trial: 33061822
Drug: Glucagon-like peptide-1
RxNorm normalized name: Glucagon-like peptide-1 (GLP-1) analogues
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucagon-like peptide-1 receptor agonist (GLP-1RA)
Trial: 39323258
Drug: Oral morphine
RxNorm normalized name: morphine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral morphine
Trial: 32315295
Drug: Letrozole monotherapy
RxNorm normalized name: Letrozole
DrugBank: Letrozole (DB01006)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Letrozole monotherapy in real-world cohort
Trial: 33630863
Drug: Stockholm3 Model
RxNorm normalized name: Stockholm tar
DrugBank: Pine tar (DB15840)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stockholm3 Model (S3M) test with reflex thresholds of 1.5 ng/mL
Trial: 32338459
Drug: Both test
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both test and reference drugs
Trial: 34510814
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist (leuprorelin acetate or goserelin acetate)
Trial: 33285649
Drug: Active-unassisted robotic
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active-unassisted robotic therapy (n=8)
Trial: 33285649
Drug: Active-assisted robotic
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active-assisted robotic therapy (n=6)
Trial: 32247531
Drug: Insulin-dextrose infusion
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin-dextrose infusion for 120 minutes
Trial: 32247531
Drug: Insulin-dextrose infusion
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin-dextrose infusion at 1.5 mU/kg/minute for 60 minutes
Trial: 32247531
Drug: Insulin-dextrose infusion
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin-dextrose infusion at 0.5 mU/kg/minute for 60 minutes
Trial: 33546963
Drug: Povidone iodine-based
RxNorm normalized name: Povidone-Iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Povidone iodine-based rigid lens disinfecting solution
Trial: 32804892
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment with FMR and TFL
Trial: 32506858
Drug: Chlorhexidine solution
RxNorm normalized name: CHLORHEXIDINE GLUCONATE 99.0 g in 1 L TOPICAL SOLUTION [CHLORHEXIDINE Solution]
DrugBank: Chlorhexidine (DB00878)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorhexidine solution 0.2%
Trial: 32598093
Drug: Adjunctive antidepressant
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive antidepressant treatment (late starters excluded)
Trial: 35544051
Drug: Microneedle array
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Microneedle array (MNA-10%) - 0.25 µg per patch, administered twice, 3 weeks apart
Trial: 34578973
Drug: Caloric restriction
RxNorm normalized name: Chloric acid
DrugBank: Chloric acid (DB14150)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caloric restriction with n-3 PUFA supplementation (1.8 g/day)
Trial: 33713235
Drug: Low-dose ozone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose ozone therapy
Trial: 38654565
Drug: P2Y12 inhibitor
RxNorm normalized name: Fibrinolysis inhibitor
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: P2Y12 inhibitor monotherapy
Trial: 35691326
Drug: Short treatment
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short treatment group (500 mg intravenous imipenem-cilastatin four times a day for 72 hours)
Trial: 35691326
Drug: Extended treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended treatment group
Trial: 34512522
Drug: Routine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine treatment plus acupuncture
Trial: 34512522
Drug: Routine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine treatment plus sham acupuncture
Trial: 32821737
Drug: Both formulations
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both formulations
Trial: 32195959
Drug: Acupuncture combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture combined with tamsulosin hydrochloride sustained-release capsule
Trial: 32841941
Drug: Amoxicillin dosing
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin dosing regimens
Trial: 35131532
Drug: Hyaluronic acid
RxNorm normalized name: hyaluronic acid
DrugBank: Hyaluronic acid (non-animal stabilized) (DB19175)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyaluronic acid (HA) vaginal gel
Trial: 35131532
Drug: Polycarbophil vaginal
RxNorm normalized name: glycerin/min oil/polycarbophil VAGINAL GEL (GRAM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polycarbophil vaginal (PCV) gel
Trial: 33160908
Drug: Ibuprofen plus
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen plus oxycodone
Trial: 36548927
Drug: Subcutaneous epcoritamab
RxNorm normalized name: Epcoritamab
DrugBank: Epcoritamab (DB16672)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous epcoritamab
Trial: 32272260
Drug: Beetroot juice
RxNorm normalized name: tamarind juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beetroot juice (BR) 210 mL (18.6 mmol NO3‐)
Trial: 33903052
Drug: Cold therapy
RxNorm normalized name: Deep Cold Therapy
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold therapy
Trial: 32702849
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine treatment group
Trial: 33108244
Drug: rhG-CSF combined
RxNorm normalized name: rGM-CSF
DrugBank: Sargramostim (DB00020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: rhG-CSF combined with minimal-dose Dec (G-Dec group)
Trial: 35984380
Drug: Nebulized Salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nebulized Salbutamol (5 mg) with Magnesium Sulphate (95 mg)
Trial: 35984380
Drug: Nebulized Salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nebulized Salbutamol (5 mg) alone
Trial: 35152531
Drug: Topical 5%
RxNorm normalized name: urea topical 5% topical lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 5% minoxidil
Trial: 34254405
Drug: Lanicemine (BHV-5500)
RxNorm normalized name: Lanicemine
DrugBank: Lanicemine (DB11889)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lanicemine (BHV-5500) 1.0 mg/ml (100 mg)
Trial: 34762373
Drug: Conventional basic
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional basic treatment (control group)
Trial: 34319514
Drug: Hydrogen gas
RxNorm normalized name: Hydrogen
DrugBank: Hydrogen (DB15127)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrogen gas inhalation
Trial: 35014069
Drug: ALKS 7119
RxNorm normalized name: ALKS 29
DrugBank: ALKS 29 (DB05723)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALKS 7119 (≥50 mg)
Trial: 34653384
Drug: Poloxamer 407-based
RxNorm normalized name: POLOXAMER 407
DrugBank: Poloxamer 407 (DB11252)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Poloxamer 407-based 0.75% ropivacaine hydrogel (22.5 mg)
Trial: 33444565
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D supplementation (60,000 IU monthly)
Trial: 34836014
Drug: ASI +
RxNorm normalized name: ISOPROPYL ALCOHOL 43 mL in 60 mL TOPICAL GEL [ASI Chemicals Hand Sanitizer]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASI + I (Inositol‐enhanced bonded arginine silicate) 1600 mg
Trial: 33148502
Drug: RSA-biofeedback with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RSA-biofeedback with treatment as usual (BFB + TAU)
Trial: 35984478
Drug: POC-guided insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: POC-guided insulin adjustment
Trial: 34037666
Drug: WIV04 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WIV04 vaccine (5 µg/dose; n=13,459)
Trial: 34037666
Drug: HB02 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HB02 vaccine (4 µg/dose; n=13,465)
Trial: 39283627
Drug: Erenumab 70
RxNorm normalized name: Erenumab 70 mg/mL solution for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erenumab 70 mg
Trial: 36074703
Drug: Ultrasound-assisted carbon
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ultrasound-assisted carbon nanoparticle suspension (CNS) mapping
Trial: 34028623
Drug: All-inside tibial
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All-inside tibial socket preparation (Group 2)
Trial: 32762672
Drug: Low-dose exogenous
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose exogenous surfactant (20 mg/kg)
Trial: 32715866
Drug: Telehealth intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Telehealth intervention in pre-hospital and acute-care settings (n=11; 14.3%) for assessment and in rehabilitation and follow-up (n=61; 79.2%) for therapy delivery.
Trial: 34878625
Drug: LY-CovMab 30
RxNorm normalized name: LYS
DrugBank: Lysine (DB00123)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: LY-CovMab 30 mg, 150 mg, 600 mg, 1200 mg, 2400 mg
Trial: 34878625
Drug: LY-CovMab 150
RxNorm normalized name: LYS
DrugBank: Lysine (DB00123)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: LY-CovMab 150 mg
Trial: 34878625
Drug: LY-CovMab 600
RxNorm normalized name: LYS
DrugBank: Lysine (DB00123)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: LY-CovMab 600 mg
Trial: 32727558
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D supplementation (100,000 IU oral drop daily for 5 days)
Trial: 36008574
Drug: Yttrium-90 (Y90)
RxNorm normalized name: yttrium
DrugBank: Yttrium Y-90 (DB13076)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yttrium-90 (Y90) radioembolization with chemotherapy
Trial: 37993169
Drug: Physiotherapy treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiotherapy treatment
Trial: 38082486
Drug: Empagliflozin 10
RxNorm normalized name: empagliflozin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empagliflozin 10 mg once daily
Trial: 35997620
Drug: Overall treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall treatment groups
Trial: 34058036
Drug: Oral itraconazole
RxNorm normalized name: Itraconazole
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral itraconazole
Trial: 35963802
Drug: Olpasiran 75
RxNorm normalized name: Olpasiran
DrugBank: Olpasiran (DB19001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olpasiran 75 mg (Non-Japanese group)
Trial: 32484629
Drug: vehicle lotion
RxNorm normalized name: meningococcal group B vaccine / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle Prefilled Syringe [Bexsero]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: vehicle lotion
Trial: 33320381
Drug: Low-dose ticagrelor
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose ticagrelor (LD group, 45 mg twice daily)
Trial: 34173969
Drug: UVA therapy
RxNorm normalized name: UVA URSI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UVA therapy
Trial: 35983530
Drug: Conventional alteplase
RxNorm normalized name: Alteplase
DrugBank: Alteplase (DB00009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional alteplase and butalbital treatment
Trial: 37217903
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy followed by surgery
Trial: 32270440
Drug: Imeglimin (IMEG)
RxNorm normalized name: Fosaprepitant Dimeglumine
DrugBank: Imeglimin (DB12509)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Imeglimin (IMEG) 1500 mg twice daily with Sitagliptin (SITA) 100 mg once daily
Trial: 33228458
Drug: Willingness to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Willingness to enroll in a clinical trial for a COVID-19 vaccine
Trial: 35379019
Drug: Saline Solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline Solution (SS)
Trial: 36342475
Drug: Clopidogrel 75mg
RxNorm normalized name: clopidogrel 75 MG
DrugBank: Clopidogrel (DB00758)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Clopidogrel 75mg once daily
Trial: 32447856
Drug: Electroacupuncture at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroacupuncture at Baihui (GV20) and Shuigou (GV26) points in addition to routine western medicine treatment.
Trial: 32725861
Drug: Routine speech
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine speech therapy intervention
Trial: 38221601
Drug: Parent-Child Interaction
RxNorm normalized name: Senna-Relief Childs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parent-Child Interaction Therapy-Emotion Development (PCIT-ED)
Trial: 32471808
Drug: Intravenous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous lidocaine treatment
Trial: 34671996
Drug: Namodenoson 25
RxNorm normalized name: Namodenoson
DrugBank: Namodenoson (DB12885)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Namodenoson 25 mg b.d.
Trial: 33044367
Drug: CUR +
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CUR + FEN (500 mg·d)
Trial: 32984946
Drug: Polaprezinc (PZ)
RxNorm normalized name: polaprezinc
DrugBank: Polaprezinc (DB09221)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polaprezinc (PZ) lozenge treatment
Trial: 33355079
Drug: Sequential regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential regimen (Group B): omeprazole and amoxicillin for 5 days, followed by omeprazole, tinidazole, and levofloxacin for 5 days.
Trial: 33393835
Drug: Galcanezumab 240
RxNorm normalized name: Galcanezumab
DrugBank: Galcanezumab (DB14042)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Galcanezumab 240 mg (EM from placebo-controlled trial)
Trial: 33393835
Drug: Galcanezumab 240
RxNorm normalized name: Galcanezumab
DrugBank: Galcanezumab (DB14042)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Galcanezumab 240 mg (CM)
Trial: 35366920
Drug: L-carnitine (L-C)
DrugBank: Levocarnitine (DB00583)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-carnitine (L-C)
Trial: 36865252
Drug: Diuretics
RxNorm normalized name: DIURETICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretics
Trial: 33217362
Drug: Low-dose CoronaVac
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose CoronaVac (3 μg per 0.5 mL)
Trial: 33095777
Drug: Pre-operative home-based
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pre-operative home-based exercise therapy with one exercise